Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Cash & Current Investments (2022 - 2026)

Moolec Science (MLECW) posted Cash & Current Investments of $1.2 million for Q1 2026, up 20.0% sequentially from $1.0 million in Q4 2025.

Moolec Science (MLECW) Cash & Current Investments (2022 - 2026) Analysis & Trends

Moolec Science has reported Cash & Current Investments for 5 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Cash & Current Investments changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $9.0 million, down 86.67% from the prior year.
  • Cash & Current Investments grew to $1.2 million in Q1 2026 per MLECW's latest filing, from $1.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $228.0 million in Q1 2023 and troughed at $853857.0 in Q3 2023.
  • A 5-year average of $33.1 million and a median of $9.0 million in 2025 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2024: Cash & Current Investments soared 19030.68% in 2023, then tumbled 98.14% in 2024.
  • Over 5 years, Cash & Current Investments stood at $10.4 million in 2022, then surged by 320.91% to $43.9 million in 2023, then retreated by 2.98% to $42.6 million in 2024, then sank by 97.65% to $1.0 million in 2025, then rose by 20.0% to $1.2 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $1.2 million, $1.0 million, and $9.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Moolec Science 8,617.72 -1.19 Mn - 1.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.00 Mn
Jun 30, 2025 9.02 Mn
Dec 31, 2024 42.59 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 67.66 Mn
Mar 31, 2024 4.25 Mn
Dec 31, 2023 43.90 Mn
Sep 30, 2023 853,857.00
Jun 30, 2023 49.57 Mn
Mar 31, 2023 228.00 Mn
Dec 31, 2022 10.43 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 32.80 Mn
Mar 31, 2022 1.19 Mn